Kowa Company, Ltd: Pharmaceuticals and Healthcare Company Profile & SWOT ReportiCD ResearchFebruary 2, 2012 19 Pages - SKU: ICDR6793080 |
| Synopsis ICD Research's Kowa Company, Ltd: Pharmaceuticals and Healthcare Company Profile & SWOT Report contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company. Summary ICD Research's Kowa Company, Ltd: Pharmaceuticals and Healthcare Company Profile & SWOT Report is a crucial resource for industry executives and anyone looking to access key information about Kowa Company, Ltd.. ICD Research's Kowa Company, Ltd: Pharmaceuticals and Healthcare Company Profile & SWOT Report report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope
Kowa Company, Ltd. (Kowa) is a manufacturer and marketer of pharmaceuticals, broadcasting devices, optical instruments and electronic devices. The company also undertakes trading of textile, apparel, machinery, chemicals, building materials and consumer products. The over the counter (OTC) products offered by Kowa includes dermatological products, gastrointestinal products, respiratory products, topical analgesic products, vitamins, and quasi-drugs. The company classifies its business into five divisions: Pharmaceutical, Electronics & Optics, Lifestyle Business, Industry & Chemical and Business Development. Kowa operates offices and factories in Japan, New York, Durham, Los Angeles, Paris, Dusseldorf, Milan, Santiago, London, Dalian, Beijing, Shanghai, Taipei, Hong Kong, Singapore, Davao, Jakarta, and Bangkok. The company was founded in 1894 and is headquartered in Aichi, Japan. |
Related Markets
Pharmaceuticals Company Reports
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2012
- Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
- Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics
- Partnerships, Licensing, Investments and M&A Deals and Trends for March 2012 in Pharmaceuticals
- Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs
